Atea Pharmaceuticals, Inc. (AVIR) Insider Trading -- Recent Executive & Director Transactions

13 insiders reported 28 Form 4 transactions for Atea Pharmaceuticals, Inc. (AVIR) over the past 18 months (most recent 2026-06-23). Recent activity: BERGER FRANKLIN M (Director) Buy 29,600 shares, DUNCAN BARBARA GAYLE (Director) Buy 29,600 shares, Polsky Bruce (Director) Buy 29,600 shares, Murphy Polly A. (Director) Buy 29,600 shares, Lucidi Bruno (Director) Buy 29,600 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-23BERGER FRANKLIN MDirectorBuy29,600$0
2026-06-23DUNCAN BARBARA GAYLEDirectorBuy29,600$0
2026-06-23Polsky BruceDirectorBuy29,600$0
2026-06-23Murphy Polly A.DirectorBuy29,600$0
2026-06-23Lucidi BrunoDirectorBuy29,600$0
2026-06-23Adams Jerome M.DirectorBuy29,600$0
2026-05-21Murphy Polly A.DirectorBuy6,100$25,446
2026-05-20Murphy Polly A.DirectorBuy6,100$25,446
2026-03-13Corcoran AndreaSee RemarksBuy60,000$74,400
2026-02-03Horga Maria ArantxaChief Medical OfficerBuy51,283$0
2026-02-03Sommadossi Jean-PierrePresident, CEO, and ChairmanSell106,093$449,834
2026-02-03Sommadossi Jean-PierrePresident, CEO, and ChairmanBuy300,000$372,000
2026-02-03Sommadossi Jean-PierrePresident, CEO, and ChairmanBuy272,983$0
2026-02-03Horga Maria ArantxaChief Medical OfficerSell16,073$68,150
2026-02-03Vavricka JohnChief Commercial OfficerBuy42,083$0
2026-02-03Vavricka JohnChief Commercial OfficerSell11,570$49,057
2026-02-03Foster WayneEVP, Chief Accounting OfficerBuy41,333$0
2026-02-03Foster WayneEVP, Chief Accounting OfficerSell12,132$51,440
2026-02-03Corcoran AndreaSee RemarksBuy54,866$0
2026-02-03Corcoran AndreaSee RemarksSell16,104$68,281
2026-02-03Hammond Janet MJChief Development OfficerBuy58,050$0
2026-02-03Hammond Janet MJChief Development OfficerSell14,136$59,937
2025-06-24Murphy Polly A.DirectorBuy29,600$0
2025-06-24Lucidi BrunoDirectorBuy29,600$0
2025-06-24BERGER FRANKLIN MDirectorBuy29,600$0

Source: SEC Form 4 filings · as of 2026-06-23